ResearcherKanazawa UniversityNo recent work listed
Seiji Yano
Matched on ORCID iD 0000-0002-6151-2988; OpenAlex author ID A5017882443, A5111700491. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2012: 2 papers · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 4
- Clinical outcome of patients with inoperable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus Nab‑paclitaxel as a first‑line therapy: A retrospect… Last author DOI 10.3892/mi.2021.8↗
- Expression of Akt kinase-interacting protein 1, a scaffold protein of the PI3K/PDK1/Akt pathway, in pancreatic cancer. Last author DOI 10.1097/mpa.0000000000000168↗
- Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/pin.12020↗
- Endoscopic findings of upper gastrointestinal lesions in patients with pancreatic cancer. Last author DOI 10.6092/1590-8577/749↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Koushiro Ohtsubo · 3 shared papers, 2012–2021 · strength 0.20
- Paper Clinical outcome of patients with inoperable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus Nab‑paclitax… DOI 10.3892/mi.2021.8↗
- Paper Expression of Akt kinase-interacting protein 1, a scaffold protein of the PI3K/PDK1/Akt pathway, in pancreatic cancer. DOI 10.1097/mpa.0000000000000168↗
- Paper Endoscopic findings of upper gastrointestinal lesions in patients with pancreatic cancer. DOI 10.6092/1590-8577/749↗
- Hiroyuki Sakaguchi · 1 shared paper, 2021 · strength 0.12
- Tetsuo Ohta · 1 shared paper, 2014 · strength 0.04
- Yoshitsugu Tajima · 1 shared paper, 2012 · strength 0.03
- Yasunari Kawabata · 1 shared paper, 2012 · strength 0.03
- Keizo Takenaga · 1 shared paper, 2012 · strength 0.03
- Takeshi Urano · 1 shared paper, 2012 · strength 0.03
- Takeshi Nishi · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.